Option Care Health (OPCH) Stock: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$31.27
-0.02 (-0.08%)
▼
5d:
+0.21%
30d:
+36.29%
90d:
+43.35%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 29, 2026
5d
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OPCH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OPCH shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.04
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$24.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $31.27, which is considered extended relative to its 30-day fair value range of $23.14 to $30.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.0) compared to its historical average (13.5). At these levels, the market is pricing in 3.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OPCH is in a strong uptrend. The price is currently testing key support at $31.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OPCH scores 14/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPCH is in a strong uptrend. The price is currently testing key support at $31.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OPCH scores 14/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.14 -
$30.93
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (14/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($30.03)
- NEUTRAL: Market pricing in 3.7% annual earnings growth - fairly valued
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.14 -
$30.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$31.07
Resistance Level
$31.38
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.02
Wall Street Target
$30.03
(-4.0%)
Revenue Growth (YoY)
1.9%
Earnings Growth (YoY)
12.9%
Profit Margin
3.7%
Valuation Premium vs History
+3.7% premium
PE vs Historical
15.0 vs 13.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.7%
(market-implied from PE analysis)
1-Year Target
$32.45
(+4%)
2-Year Target
$33.65
(+8%)
3-Year Target
$34.89
(+12%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$31.36
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 10.7%)
$56.05
(+79%)
Base:
(SPY PE: 15.0, Growth: 10.7%)
$42.40
(+36%)
Bear:
(PE: 12.8, Growth: 10.7%)
$36.04
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 23.70 | Current EPS (TTM): $1.32
Bull Case
$54.31
(+74%)
Analyst growth 57.8%, PE expands to 26.1
Base Case
$49.37
(+58%)
Market implied 57.8%, PE stable at 23.7
Bear Case
$21.28
(-32%)
Severe decline -20.0%, PE contracts to 20.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 51 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 49 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 50 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 54 HOLD |
